micro-community-banner
 
  • Saved

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

Source : https://care.diabetesjournals.org/content/early/2021/10/12/dc21-0437

OBJECTIVE Irregular menstrual cycles are associated with increased cardiovascular mortality. Polycystic ovary syndrome (PCOS) is characterized by androgen excess and irregular menses; androgens are drivers of increased metabolic risk in...

  • Saved

  • Saved

Fasting plasma glucose level in the range of 90 to 99 mg/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2.

Fasting plasma glucose level in the range of 90 to 99 mg/dL and the risk of the onset of type 2 diabetes: Population-based Panasonic cohort study 2.

Source : https://europepmc.org/article/med/34624178

Aim/introduction As the association between fasting glucose concentration from 90 to 99 mg/dL and the onset of type 2 diabetes is still controversial, we aimed to assess it in 37,148...

  • Saved

  • Saved

I would stop sulfonylurea due to risk of hypoglycemia and DPP IV. I would continue metformin and add a GLP 1 to help with weight loss and cardiovascular protection.

  • 4yr
    I would discontinue the Sulfonylurea and DPP4 since she is not achieving the goal, I would recommend putting her on SGLT2 Inhibitor which has proven benefits on the kidney, CHF, Show More